Access to multiple tobacco flavors to help adult cigarette smokers quit using e-cigarettes
Official title: An Extension Study to Determine the Effect of Access to Multiple Tobacco Flavor Options on Smoking Abstinence Among Primary Combustible Cigarette Smokers Using an Electronic Nicotine Delivery System, With Comparison to a Single Tobacco Flavor Comparator Arm From an Earlier Randomized Controlled Trial
Run by RAI Services Company · NCT07879638 · Data updated 2026-11-12
This study tests whether giving adult smokers an e-cigarette with a choice of flavors helps them quit smoking by the end of 13 weeks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 65 Years |
| Sex | All |
| Enrollment | 480 (estimated) |
| Sponsor | RAI Services Company Industry-sponsored |
| Locations | 5 sites (Fort Lauderdale, Florida and 4 other locations) |
| Status | Recruiting |
| Started | September 30, 2026 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT07879638 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 21–65 who smoke daily, are willing to use ENDS, own a smartphone, and can read and sign consent.
✕Probably not a fit
Participants who do not quit smoking may not experience a direct benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multi-site, open-label, single-arm trial that looks at end-of-study smoking abstinence in healthy adult cigarette smokers who are provided an electronic nicotine delivery system with multiple flavor options over 13 weeks. Results will be compared to a prior randomized trial that used a single flavor. Participants will use a study app to report surveys and may receive a study-provided phone for study activities. The study is sponsored by RAI Services Company and conducted at three U.S. sites.
Why it matters
Potential benefit: If successful, participants may experience higher chances of quitting smoking with the help of flavored ENDS.
How similar studies have gone: Previous research with ENDS and flavor options has shown mixed results; this trial builds on prior work by adding flavor choice in a real-world setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Able to read, understand, and are willing to sign an Informed Consent Form (ICF) and complete questionnaires written in English. * Generally healthy male or female, between 21 and 65 years of age, inclusive, at the time of consent. * All female (assigned at birth) and those who identify as "intersex" or "unknown candidate" participants who agree to take the pregnancy test on site and receive a negative result, and who affirm at SEV that they are not pregnant or intending to become pregnant. * Currently smoke at least 5 CC on smoking days in the past 30 days. * Smoke CC on 15 or more of the past 30 days. * Smoked at least 100 factory-made CC in their lifetime prior to the SEV. * Indicate a willingness to use ENDS. * Own and regularly use a smartphone (iOS or Android) with internet access to download a study application to access surveys and the capability to receive notifications or be willing to use a study-provided phone for surveys and other required study activities. * Agree to participate in the study and to abide by the study restrictions and requirements, as described in the ICF. Exclusion Criteria: * Female participants who are pregnant or breastfeeding or planning to become pregnant or start breastfeeding within the next 6 months based on self-report. * Male participants who self-report they are not willing to use a barrier method of contraception (e.g., a condom with spermicide) or refrain from donating sperm from the time of the signing of the ICF until the end of the study, unless they have undergone a vasectomy or are abstinent from heterosexual intercourse, or their female partner was not able to bear children. * Female participants who self-report not using adequate methods to prevent pregnancy. * Persons with pacemakers or other embedded electronic medical devices fitted. * Participants who self-report having an unstable heart condition, severe hypertension or diabetes. * Persons who self-report they are allergic/sensitive to cosmetics or fragrances or any ingredient listed in commercial e-cigarette products. * Participants who self-report poor physical or mental health. * Participants who have used ENDS, nicotine pouch, smokeless tobacco (i.e., chewing tobacco, snus, or snuff) products, heated tobacco products, or other combustible products and other oral nicotine products (tablets, gums, lozenges) on 11 or more days in the past 30 days. * Participants who have used a nicotine replacement therapy (NRT) product or a prescription drug to help stop smoking (e.g., varenicline, bupropion) in the past 30 days. * Participants who do not own a smartphone that meets the minimum technical requirements to run the survey app. * Employee of a company that manufactures tobacco or ENDS products. * Persons who are personally, have household members, or have close family or friends in litigation with a company that manufactures tobacco or ENDS products. * Have taken part in a tobacco/nicotine research study in the past 30 days.
Where it's running
-
MARS Research
Fort Lauderdale, Florida, United States Recruiting -
Sago Atlanta
Atlanta, Georgia, United States Recruiting -
Sago Chicago
Chicago, Illinois, United States Recruiting -
Sago New Jersey
Iselin, New Jersey, United States Recruiting -
Sago Dallas
Dallas, Texas, United States Recruiting
Study contacts
- Study coordinator: Montgomery Hedgecock
- Email: montgomery_hedgecock@rjrt.com
- Phone: 336-741-3761
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heated tobacco access and cigarette quitting among adult smokers
This study tests whether giving adult smokers access to a heated tobacco product helps them quit smoking by the end of 3 months.
-
How flavors of ENDS might help adults quit smoking their usual cigarettes
This study tests whether giving adults who smoke their regular cigarettes an electronic nicotine delivery system with different flavors can help them quit smoking their usual cigarettes after 3 months.
-
Salivary IL-8 and Serum IL-6 as Biomarkers to Distinguish Oral Premalignant Disorders in Smokers and Never-Smokers
This study tests whether salivary IL-8 and blood IL-6 can help tell apart adults with oral premalignant conditions from those with healthy mouths, and whether smoking influences these markers.
-
Smoking, MFN1, and NLRP3 Levels in Gum Fluid Across Periodontal Health and Disease
This study tests whether smoking changes MFN1 and NLRP3 protein levels in the fluid around the gums for adults with or without periodontitis.
-
Abuse liability and use patterns of IQOS heated tobacco among adult smokers
The study tests how appealing and user-friendly IQOS heat sticks are for adults who smoke, and compares how people puff and use IQOS versus their usual cigarettes.
-
Communal coping in couples where both partners smoke during a quit attempt
This project tests whether couples who tackle quitting as a team (communal coping) fare better when one partner in a smoking couple tries to quit.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.